Improving Personalized Treatment in Oncology: Effects of Integrated Oncological Decision-making

Launched by LEIDEN UNIVERSITY MEDICAL CENTER · Jun 23, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new way to help doctors and patients make cancer treatment decisions together. The approach, called the Integrated Oncological Decision-making Model (IODM), looks at medical options, the patient’s overall health, and what the patient wants from their treatment. The goal is to see if this personalized method leads to treatment choices that better fit each patient’s needs and improve their outcomes compared to standard care based only on medical guidelines.

Adults aged 18 and older who are starting cancer treatment at one of four medical centers in the Netherlands may be eligible to join, as long as they can understand Dutch and participate in making decisions about their care. About 400 patients will take part. Some will receive usual care, while others will use the new IODM approach. Participants can expect to be involved in discussions about their treatment options, share their health status and personal goals, and complete questionnaires about their experience. This study aims to better tailor cancer treatments to individual patients, making the decision process more personalized and meaningful.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient's age = 18+
• • Patient is included in participating oncological care path
• • Patient does not yet have a treatment plan
• • Patient, partner, or caregiver who reads and speaks Dutch sufficiently to understand the research material and to complete the questionnaires
• • Patient must be able to participate in the decision-making process
• Exclusion Criteria:
• • • Patient, partner, or caregiver cannot give informed consent